Saturday, July 11, 2026

Drug profile · INN

tirofiban

tirofiban (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — tirofiban

Quick answer

tirofiban (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN tirofiban
Brand AGGRASTAT
Mechanism Integrin alpha-IIb/beta-3 inhibitor

Mechanism of action

Integrin alpha-IIb/beta-3 inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Intravenous thrombolysis plus tirofiban Phase 3 · Chinese Academy of · Acute Ischemic Stroke
  2. Intravenous thrombolysis plus tirofiban Phase 3 · Hospital Authority · Acute Ischemic Stroke
  3. Tirofiban Phase 3 · Universal Integrated · Acute Ischemic Stroke
  4. tirofiban in PV Phase 1 · Chinese Academy of · Coronary Artery Disease
  5. Tirofiban hydrochloride sodium chloride injection Approved · Chinese Academy of · Branch Atheromatous Disease

Frequently asked questions

What is tirofiban?

tirofiban (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for tirofiban?

AGGRASTAT is a marketed brand name for tirofiban. Check FDA Drugs@FDA for the current US label holder and prescribing information.